New genes identified for fibromuscular dysplasia

Genetic meta-analysis helps researchers detect genes related to this cardiovascular disease that affects mostly women and defines relationships to other more common cardiovascular conditions.

5:00 AM

Author | Haley Otman

image of drawing of gene in blue ink on lined paper with lab note written on bottom right
Michigan Medicine

Three new genetic variants that regulate gene expression in the arteries are connected to fibromuscular dysplasia, an arterial disease that can cause dangerous consequences for the heart and vessels, according to a new study.

The findings, published in Nature Communications by an international team of FMD experts from the United States and Europe, also confirmed the importance of a fourth genetic target that has already been identified as involved with the disease.

"We once thought FMD was a rare disease, but the current estimate is that it may affect more than 3% of the population," said co-senior and co-corresponding author Santhi Ganesh, M.D., an associate professor of internal medicine and human genetics, and a cardiologist at the University of Michigan Health Frankel Cardiovascular Center. "It's vital that we continue this research to better understand what causes FMD. The disease primarily affects women in the prime of their lives, and the diagnosis often comes after a dangerous cardiovascular complication such as severe high blood pressure, a stroke, or a heart attack."

Researchers note the genes identified suggest that the genetic basis of FMD may contribute through altered vascular smooth muscle cell structure and function.

Notably, the genetic findings pointed to a correlation with several more common cardiovascular diseases that are often reported in tandem with FMD, including high blood pressure, migraine headache, intracranial aneurysm and subarachnoid hemorrhage. There was a negative correlation to atherosclerotic coronary artery disease, while no shared genetics were confirmed with ischemic stroke, which also commonly affects people with FMD.

"The findings provide new biologic insights into this intriguing condition and genes and pathways to study further, toward the goal of identifying therapeutic targets for FMD," said co-senior and co-corresponding author Nabila Bouatia-Naji, Ph.D., director of research at France's Institut National de la Santé et de la Recherche Médicale, also known as INSERM and team leader at the Paris Cardiovascular Research Center.

Ganesh and Bouatia-Naji's team combed through data from genome-wide association studies of more than 1,500 FMD cases, comparing them to more than 7,000 control samples from participants without FMD. The three new genes implicated for FMD are ATP2B1, LRP1 and LIMA1, while the fourth that was confirmed is known as PHACTR1.

"This is the most comprehensive genetic investigation of FMD to date, and was made possible through the collective efforts of our international research teams," Ganesh noted.

Paper cited: "Genetic investigation of fibromuscular dysplasia identifies risk loci and shared genetics with common cardiovascular diseases," Nature Communications. DOI: 10.1038/s41467-021-26174-2

SEE ALSO: Uncovering the Genetics Behind Heart Attacks That Surprise Young, Healthy Women


More Articles About: Lab Notes Heart disease Heart Disease in Women Genetic Disorders Genetic Testing Cardiovascular: Diseases & Conditions
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of health care news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe
Featured News & Stories looking at surgeons operating in room with scrubs and scrub hats on through a door window
Health Lab
1 in 5 older adults get infections after heart surgery, and women have a 60% higher risk
According to findings by Michigan Medicine, one in five older patients gets an infection up to six months following heart surgery — with women much more likely to develop one.
man and woman in front of stadium with crowd at UM
Health Lab
Longtime Michigan football announcer makes call on heart health
A famous sports announcer for University of Michigan football finds himself getting heart care at Michigan Medicine and spreading the word to others to be proactive about their heart health.
The surgical team poses in the OR after the first implantation for the trial at U-M.
News Release
National study underway to test new mechanical heart pump, led by U-M Frankel Cardiovascular Center
A cardiac surgery team at the University of Michigan implanted a novel mechanical heart pump into a patient as part of a clinical trial that will compare it to the only device currently used to treat end-stage heart failure.
woman walking on treadmill picking intensity on a chart that reads from easier to harder
Health Lab
Higher costs limit attendance for life changing cardiac rehab
Despite the success cardiac rehabilitation has shown at reducing heart-related deaths and hospital readmissions, higher out-of-pocket costs may prevent patients from participating in the program, a University of Michigan study suggests. 
prescription pad drawn
Health Lab
Reducing dose of popular blood thinners may limit risk of future bleeding
For people taking the popular blood thinners rivaroxaban (brand name Xarelto) and apixaban (brand name Eliquis), after having a blood clot, a reduced dose may limit the future risk of bleeding as well as hospital visits, a Michigan Medicine-led study suggests.
older man with glasses standing at balcony with back to glass windows
Health Lab
Roy’s Michigan Answer: Second opinion saves patient’s heart
Michigan Medicine's team of cardiology experts offered an advanced, minimally invasive coronary intervention, which restored one patient back to good health